Compound Radar

DENTSPLY SIRONA Inc. (XRAY) Stock Analysis

Price $10.99
Market cap $2.19B
Next earnings Nov 5, 2026
Entry status Wait

Last updated Sep 8, 2026

Health Check

Last analyzed Sep 7, 2026

46
46/100 Speculative
  • Financial Health 50
  • Profitability 30
  • Business Quality 60
  • Balance Sheet 40
  • Cash Flow 45

Why this rating?

Health 46/100 — Speculative

Strongest Business Quality 60/100
Softest Profitability 30/100
Wait

Entry timing is weak right now. Quality may be fine; the setup is not.

Company overview

DENTSPLY SIRONA Inc. (XRAY) is a Medical Instruments & Supplies company in the Healthcare sector. Compound Radar rates DENTSPLY SIRONA Inc. 46/100 (Speculative) due to solid business quality, elevated leverage, and attractive valuation.

Investment profile

  • Quality Moderate
  • Growth Soft
  • Balance Sheet Stretched
  • Valuation Attractive

Financial highlights

Valuation

  • Forward P/E 7.24
  • PEG 0.74
  • EV/Revenue 1.2

Profitability

  • Revenue Growth -4.1%
  • Gross Margin 49.5%
  • Operating Margin 9.2%
  • Net Margin -15.0%
  • ROE -33.0%

Financial strength

  • Cash $239.00M
  • Debt $2.33B
  • Net Cash $-2.09B
  • Free Cash Flow $104.00M
  • Current Ratio 1.63

Similar companies

Peers in Medical Instruments & Supplies, ranked by Financial Health.

Company Ticker
Price Current price

Latest quoted price for the name. Helps anchor the setup in today’s market level.

Health Entry

View all in Medical Instruments & Supplies →

FAQ

How Compound Radar scores and tracks DENTSPLY SIRONA Inc. (XRAY).

View Methodology & FAQ →